Press Releases Year None202420232022202120202019 Apr 11, 2024 Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics Apr 08, 2024 Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting Mar 19, 2024 Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference Mar 14, 2024 Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates Mar 05, 2024 Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting Feb 01, 2024 Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference Dec 09, 2023 Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits Dec 06, 2023 Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus Dec 06, 2023 Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus Nov 21, 2023 Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference First page « Previous page ‹ Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Next page › Last page » Displaying 11 - 20 of 79
